The following are indicated:

Pharmacologic treatment of dystonia and spasticity, including consideration of oral baclofen, trihexyphenidyl, intramuscular botulinum toxin, and a trial of intrathecal baclofen if indicated

Pharmacologic treatment of parkinsonism (response to levodopa has been variable in this population)

Treatment by a psychiatrist for those with significant neuropsychiatric symptoms

Physical, occupational, speech, and other therapies as indicated

Use of a liquid nutritional supplement to help maintain weight as needed

A gastric feeding tube to help minimize weight loss (which becomes more frequent with disease progression) and to reduce the risk of aspiration pneumonia

Glycopyrrolate or transdermal scopolamine patch to reduce the volume of secretions in those with excessive drooling or difficulty controlling secretions

Tracheostomy as indicated for difficulty managing secretions

Over-the-counter fiber supplements and/or stool softeners to treat constipation, which is likely caused by a combination of immobility, diet, and medications
